Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127486381 | 12748638 | 1 | I | 20160906 | 20160915 | 20160915 | EXP | GB-GLAXOSMITHKLINE-GB2016GSK133439 | GLAXOSMITHKLINE | BRODIE MJ. PHARMACOLOGICAL TREATMENT OF DRUG-RESISTANT EPILEPSY IN ADULTS:A PRACTICAL GUIDE. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS. 2016;16 (82):1 - 9 | 0.00 | F | Y | 0.00000 | 20160915 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127486381 | 12748638 | 1 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | UNK | U | 0 | ||||||||||
| 127486381 | 12748638 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 1500 MG, BID | U | 0 | 1500 | MG | BID | |||||||
| 127486381 | 12748638 | 3 | SS | ZONISAMIDE. | ZONISAMIDE | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 4 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 5 | SS | VALPROATE | VALPROIC ACID | 1 | UNK | U | 0 | ||||||||||
| 127486381 | 12748638 | 6 | SS | VALPROATE | VALPROIC ACID | 1 | 700 MG, BID | U | 0 | 700 | MG | BID | |||||||
| 127486381 | 12748638 | 7 | PS | Retigabine | EZOGABINE | 1 | U | 22345 | |||||||||||
| 127486381 | 12748638 | 8 | SS | LACOSAMIDE. | LACOSAMIDE | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 9 | SS | VIGABATRIN | VIGABATRIN | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 10 | SS | ACETAZOLAMIDE. | ACETAZOLAMIDE | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 11 | SS | POTASSIUM BROMIDE | POTASSIUM BROMIDE | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 12 | SS | PREGABALIN. | PREGABALIN | 1 | U | 0 | |||||||||||
| 127486381 | 12748638 | 13 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | 600 MG, BID | 0 | 600 | MG | BID | ||||||||
| 127486381 | 12748638 | 14 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 100 MG, BID | 0 | 100 | MG | BID | ||||||||
| 127486381 | 12748638 | 15 | C | PERAMPANEL | PERAMPANEL | 1 | 12 MG, QD (AT NIGHT) | 0 | 12 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127486381 | 12748638 | 1 | Product used for unknown indication |
| 127486381 | 12748638 | 3 | Product used for unknown indication |
| 127486381 | 12748638 | 4 | Product used for unknown indication |
| 127486381 | 12748638 | 5 | Product used for unknown indication |
| 127486381 | 12748638 | 7 | Product used for unknown indication |
| 127486381 | 12748638 | 8 | Product used for unknown indication |
| 127486381 | 12748638 | 9 | Product used for unknown indication |
| 127486381 | 12748638 | 10 | Product used for unknown indication |
| 127486381 | 12748638 | 11 | Seizure |
| 127486381 | 12748638 | 12 | Product used for unknown indication |
| 127486381 | 12748638 | 13 | Product used for unknown indication |
| 127486381 | 12748638 | 14 | Product used for unknown indication |
| 127486381 | 12748638 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127486381 | 12748638 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127486381 | 12748638 | Drug ineffective | |
| 127486381 | 12748638 | Drug resistance | |
| 127486381 | 12748638 | Epilepsy | |
| 127486381 | 12748638 | Sedation | |
| 127486381 | 12748638 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |